Beacon Pharmaceuticals PLC (DSE:BEACONPHAR)
Bangladesh · Delayed Price · Currency is BDT 101.40
+0.70 (0.70%)
At close: Oct 15, 2026
Beacon Pharmaceuticals Market Cap
Beacon Pharmaceuticals has a market cap or net worth of 23.42 billion as of October 15, 2026. It is the 21,150th most valuable company in the world and the 28th biggest in Bangladesh. Its market cap has decreased by 8.24% in one year.
Market Cap
23.42B
Enterprise Value
32.46B
Revenue
15.57B
Global Rank
Country Rank
#28 Bangladesh
PE Ratio
16.08
ChartMarket Cap Chart
Since August 12, 2010, Beacon Pharmaceuticals's market cap has increased from 19.93B to 23.42B, an increase of 17.52%. That is a compound annual growth rate of 1.00%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 15, 2026 | 23.42B | -3.06% |
| Dec 30, 2025 | 24.16B | -23.03% |
| Dec 30, 2024 | 31.39B | -44.53% |
| Dec 28, 2023 | 56.60B | -14.34% |
| Dec 29, 2022 | 66.07B | 17.50% |
| Dec 30, 2021 | 56.23B | 210.46% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 27, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Square Pharmaceuticals PLC. | 193.69B |
| Beximco Pharmaceuticals PLC. | 64.20B |
| Renata | 51.18B |
| Unilever Consumer Care | 38.14B |
| The ACME Laboratories | 16.34B |
| Asiatic Laboratories | 12.66B |
| The IBN SINA Pharmaceutical Industry | 9.60B |
| Navana Pharmaceuticals | 6.69B |